Boston, MA, United States of America

Adam Palermo


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Boston, MA (US) (2019 - 2023)
  • Cambridge, MA (US) (2023)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Adam Palermo

Introduction

Adam Palermo is a notable inventor based in Boston, MA (US). He has made significant strides in the field of biotechnology, particularly in the development of RNA interference (RNAi) technologies aimed at treating Huntington's disease. With a total of 5 patents to his name, Palermo's work is paving the way for new therapeutic approaches.

Latest Patents

Palermo's latest patents focus on innovative RNAi molecules designed to combat Huntington's disease. One of his key inventions involves RNAi molecules that include a first strand containing a guide sequence and a second strand with a non-guide sequence. This non-guide sequence features a bulge opposite the seed region of the guide sequences, enhancing the efficacy of the treatment. Additionally, his patents encompass expression cassettes, vectors such as rAAV, recombinant adenoviral, recombinant lentiviral, and recombinant HSV vectors, as well as cells, viral particles, and pharmaceutical compositions containing the RNAi. These inventions are crucial for developing methods and kits related to the use of RNAi in treating Huntington's disease.

Career Highlights

Adam Palermo is currently associated with Genzyme Corporation, a leading biotechnology company. His work at Genzyme has allowed him to focus on groundbreaking research and development in the field of genetic therapies. His contributions have not only advanced scientific understanding but also provided hope for patients suffering from debilitating conditions.

Collaborations

Palermo collaborates with talented professionals in his field, including Brenda Richards and Lisa M Stanek. These collaborations enhance the innovative potential of his research and contribute to the success of his projects.

Conclusion

Adam Palermo's contributions to the field of biotechnology, particularly in RNAi technologies for treating Huntington's disease, highlight his role as a leading inventor. His work continues to inspire advancements in medical science and offers hope for future therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…